Navigation Links
Bionovo Announces 2010 Highlights and Year-End Financial Results
Date:3/15/2011

EMERYVILLE, Calif., March 15, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced financial results for the year ended December 31, 2010.

"2010 was a year of important progress, especially on the regulatory front," said Isaac Cohen, O.M.D., Bionovo's Chairman and Chief Executive Officer. "Bionovo advanced the lead drug Menerba with both the FDA and EMA. Reaching agreement with the Agencies on the CMC and the overall clinical development plan to NDA clears the way forward and provides accurate development costs and timelines to potential partners. We expect to be able to initiate the Phase 3 clinical trials for Menerba early in the 3rd quarter of this year.

Key Events and Milestones

  • In 2010, the Company announced the following regarding Menerba™, its lead drug candidate for the treatment of menopausal hot flashes:
  • In December, the Company received minutes from its successful meeting with the FDA in November, confirming agreements reached on the clinical development plan for Menerba.
  • In September,  an "End of Phase 2" Type B meeting with the FDA resulted in a binding agreement on the Chemistry, Manufacturing and Control (CMC) plan for Menerba.
  • In July, the Company received formal guidance from the European Medicines Agency (EMA), defining and approving a regulatory pathway to marketing approval for Menerba in Europe.
  • The Company also had continued progress in terms of basic science and other pipeline candidates:
  • Studies were published describing:
  • how metabolic adaptability contributes to the metastasis of tumors. This work is integral to the Company's development of drugs that disrupt metabolic pathways as a mechanism.
  • the cancer prevention mech
    '/>"/>

  • SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
    2. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
    3. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
    4. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
    5. Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors
    6. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
    7. Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism
    8. Bionovo Announces Third Quarter 2010 Highlights and Financial Results
    9. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
    10. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
    11. Bionovo to Raise $3 Million Through Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... 29, 2014  Pacific Medical Data Solutions is excited ... design . The main website, along with the site,s ... new services and content relevant to the medical billing ... design, viewers can now better understand how PMDS products ... and create a more visible platform about medical billing ...
    (Date:8/29/2014)... Research and Markets  has announced the ... Devices Market 2014-2018" report to their offering. ... cells that connect, support, or surround bones. There are ... ligaments, cartilage, fascia, and other fibrous tissues. Repetitive use, ... age result in wear and tear in these tissues. ...
    (Date:8/28/2014)... NEW YORK, Aug. 28, 2014 Reportlinker.com ... available in its catalogue: North America ... 2020 http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Market Outlook to 2020 Summary GlobalData,s ... Devices Market Outlook to 2020", provides key market ...
    Breaking Medicine Technology:PMDS Announces New Website 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
    ... Hereditary hearing loss is the most common sensory disorder in ... the Institute of Human Genetics at the ... methods, including Roche,s NimbleGen Custom Sequence Capture 385K array to ... X-chromosome of a Spanish family with hereditary hearing loss (1). ...
    ... Inc. announced today that the first patient has been ... an oligoclonal therapeutic consisting of a mixture of three ... epitopes of the epidermal growth factor receptor (EGFR). ... safety of MM-151 and determine the recommended Phase 2 ...
    Cached Medicine Technology:Roche's Sequence Capture Technology Used to Identify SMPX Mutations Underlying Human Hereditary Hearing Loss 2Roche's Sequence Capture Technology Used to Identify SMPX Mutations Underlying Human Hereditary Hearing Loss 3
    (Date:8/29/2014)... Healthpointe Medical Group, one of Southern California’s ... LAXMed. The medical center is less than 2 miles from ... the 405 freeway. , The LAX clinic marks the ... is located at: 8610 S. Sepulveda Blvd., Suite 204 Los ... LAX office will provide the same comprehensive services as Healthpointe’s ...
    (Date:8/29/2014)... August 29, 2014 - Despite US Preventive Services Task ... many barriers, several of which may be ameliorated through ... at NYU Langone Medical Center published online August 21, ... ( JGIM ). , David Levine, MD, MA, ... Medicine at NYU Langone, and colleagues found that compared ...
    (Date:8/29/2014)... Today, Gen. Arthur T. Dean, Chairman ... (CADCA) , the nation’s leading substance abuse prevention organization, ... intent to nominate Michael Botticelli as the Director of ... Obama’s decision to nominate Michael Botticelli as our nation’s ... hold this important position at this time in our ...
    (Date:8/29/2014)... NORTH GRAFTON, Mass. (August 29, 2014, 2 PM ... toxin poisoning is to inject antibodies, commonly produced ... method has challenges ranging from safety to difficulties ... large quantities. , New research led by ... Infectious Disease and Global Health at the Cummings ...
    (Date:8/29/2014)... 29, 2014 (HealthDay News) -- Prostate cancer patients lacking ... decisions. This can lead to worse quality of care ... included 70 men, with a median age of 63. ... Poor understanding of the disease was associated with greater ... that the treatment would be effective, the study found. ...
    Breaking Medicine News(10 mins):Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2Health News:Options for weight loss your primary care doctor might not know about 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Mice study shows efficacy of new gene therapy approach for toxin exposures 2Health News:Faced With Prostate Cancer, It Helps to Know the Enemy 2
    ... for members and,non-union workers, SACRAMENTO, Calif., Nov. 6 ... more than 97 percent to approve a,groundbreaking new contract ... that are far ahead of the rest of the ... Workers-West (UHW) won the,agreement with their employer after six ...
    ... Genetics,Inc., (Amex: ILI ), announced today that it ... 13, 2008, at 4:30 pm EST to review the,Company,s ... on,recent corporate developments., To access the live call, ... replay access of the teleconference,will be available on the ...
    ... a strategic partner in helping,companies optimize their ... for health insurance companies that need to ... improving health risk,assessment participation to engaging members ... approach goes,beyond gift cards or rewards points., ...
    ... YORK, Nov. 6 HMS Holdings Corp. (Nasdaq:,HMSY) today ... Annual,Global Healthcare Conference, which will be held November 12-14, ... Robert Holster, CEO and Walter Hosp, CFO, will present ... Holdings Corp. (Nasdaq: HMSY ) is the nation,s ...
    ... the 2008 Excellence in Healthcare Innovation ... ... Sullivan is,pleased to announce that the firm will be presenting Dr. Ralph ... its 2008 North American Healthcare Lifetime,Achievement Award., The Award will be ...
    ... Improvements - But Overall Failing Grades, WASHINGTON, Nov. ... Cancer Alliance (LCA) marked the start of Lung Cancer ... Lung Cancer", a national,assessment of progress being made in ... improvements, but overall, failing grades continued., (Logo: ...
    Cached Medicine News:Health News:United Healthcare Workers Win New Contract with Horizon West 2Health News:United Healthcare Workers Win New Contract with Horizon West 3Health News:Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results 2Health News:Health and Wellness Incentives: How Health Insurance Providers Can Motivate and Sustain Member Participation in Wellness Programs 2Health News:Healthcare Pioneer Dr. Ralph Snyderman to Receive Frost & Sullivan's Lifetime Achievement Award 2Health News:Healthcare Pioneer Dr. Ralph Snyderman to Receive Frost & Sullivan's Lifetime Achievement Award 3Health News:Lung Cancer Alliance Releases 4th Annual Report Card on Lung Cancer 2
    ... tube extension on the proximal ... helps keep connections away from ... enhancing patient mobility and comfort. ... tubes improve tube access for ...
    Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
    Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
    Portex® pediatric tracheostomy tubes offer a choice in both form and fit. , ,The anatomical shape of the tube shaft along with the caudal angle of the 15 mm connector provide comfort and security...
    Medicine Products: